Self-guided ACT-based app for fibromyalgia management
Official title: Three-arm Randomized Controlled Trial Investigating the Effectiveness, Cost-utility, and Physiological Effects of the Spanish Version of STANZA®: A Self-guided Digital Acceptance and Commitment Therapy (ACT) for Fibromyalgia
Run by Fundació Sant Joan de Déu · NCT05962437 · Data updated 2026-11-12
A smartphone app (STANZA-Spain) plus standard care is being tested to see if it helps adults with fibromyalgia manage symptoms more effectively than a symptom-tracking app or standard care alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 360 (estimated) |
| Sponsor | Fundació Sant Joan de Déu Academic / other |
| Locations | 2 sites (Barcelona, Barcelona and 1 other locations) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | March 31, 2027 |
| Study ends | March 31, 2027 |
| Registry record updated | July 23, 2026 |
| Trial ID | NCT05962437 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with fibromyalgia (ACR 2016 criteria), FIQR 35–80 at baseline, smartphone ownership, Spanish language proficiency, and stable pain treatment.
✕Probably not a fit
Patients not experiencing improvement or those who cannot use a smartphone or adhere to digital interventions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a six‑month, three‑arm randomized trial enrolling adults with fibromyalgia to compare TAU alone, TAU plus the STANZA-Spain ACT-based app, and TAU plus a FibroST symptom-tracking app. The study will assess clinical outcomes, inflammatory biomarkers, and cost-utility from both healthcare and societal perspectives. Participants will be recruited at multiple hospitals in Spain and must own a compatible smartphone and speak Spanish. An embedded biomarker sub-study will evaluate potential predictors of response and will involve a subset of participants. The trial is led by Fundació Sant Joan de Déu with collaborators and aims to clarify whether digital ACT can add value to standard fibromyalgia care.
Why it matters
Potential benefit: If successful, the intervention could provide a scalable, digital option to improve symptoms and quality of life for people with fibromyalgia.
How similar studies have gone: Digital ACT and app-based interventions have shown promise in fibromyalgia and other chronic pain conditions, but results vary by design and population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Fibromyalgia diagnosis according to the 2016 ACR criteria * Fibromyalgia Impact Questionnaire Revised (FIQR) total score within the range of 35-80 at baseline. * Willing to maintain their current pain treatment throughout the study. * Having a smartphone (iOS 12 or higher or Android OS 8 or higher). * Proficient understanding of Spanish. Exclusion Criteria: * Presence of cognitive impairment according to clinical records. * Diagnosis of severe medical or mental disorders such as cancer, psychotic disorder, and drug abuse according to medical records. * Patients at risk of suicide. * Being pregnant or planning a pregnancy during the study period, or currently breastfeeding. * Participation in other clinical trials during the study or within the previous 12 months. * Unable to use a smartphone. Exclusion criteria for biomarkers substudy (30-50 patients in each study arm): * Male sex * Comorbid rheumatologic disorders such as lupus or severe organ dysfunction. * History of fever (\> 38ºC) or infection within the last 2 weeks. * Vaccination within the last 4 weeks. * Recent physical trauma * Needle phobia. * Consumption of more than 8 units of caffeine per day. * Smoking more than 5 cigarettes per day. * Current use of oral or topical corticosteroids. * Current use of anti-cytokine biologic medications. * Current use of oral contraceptives.
Where it's running
-
Parc Sanitari Sant Joan de Déu (PSSJD)
Sant Boi de Llobregat, Barcelona, Spain Recruiting -
Hospital Vall d'Hebrón
Barcelona, Barcelona, Spain Not yet recruiting
Study contacts
- Principal investigator: Juan V Luciano, PhD — Universitat Autònoma de Barcelona (UAB) & FSJD
- Study coordinator: Jaime Navarrete, PhD
- Email: jaime.navarrete@sjd.es
- Phone: +34936406350
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Respiratory Function in Fibromyalgia: A Look at Breath and Muscle Health in Women
This study compares respiratory function, muscle strength, and quality of life between women with fibromyalgia and healthy women to see if fibromyalgia affects breathing and muscle performance.
-
Interoceptive Sensitivity and Central Sensitization in Fibromyalgia
This study tests how people with fibromyalgia perceive internal bodily signals and whether that relates to their symptom burden.
-
Psychologically Informed Physical Therapy (PIPT) for Fibromyalgia delivered online
A small online program tests if a psychologically informed physical therapy approach is feasible, acceptable, and safe for adults with fibromyalgia to help manage symptoms and improve daily functioning.
-
Melatonin and vitamin drip for pain relief in fibromyalgia
This trial tests whether weekly intravenous vitamins plus melatonin can reduce pain and improve quality of life for adults with fibromyalgia compared with a placebo.
-
Remote electrical neuromodulation to test pain inhibition in migraine and fibromyalgia
We’re testing if the Nerivio wearable can boost the body’s natural pain-inhibition system (CPM) and reduce pain more than a sham device in adults with migraine or fibromyalgia.
-
Thickness of the thoracolumbar fascia in women with fibromyalgia
This study tests whether the thoracolumbar fascia is thicker in women with fibromyalgia compared to healthy women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.